Characteristics of drug-involved black women under community supervision; implications for retention in HIV clinical trials and healthcare.
Dawn A Goddard-EckrichOhshue S GatanagaBrittany V ThomasYang LiuDget Lynn DowneyNishita DsouzaBethany MedleyTimothy HuntElwin WuKaren A JohnsonChermaine BlackMary BrownJennifer HallNabila El-BasselLouisa GilbertPublished in: Social work in health care (2023)
This study examined retention and its relationship to mental health, substance use, and social determinants of health in a randomized clinical trial of a behavioral HIV/sexually transmitted infection prevention intervention with drug-involved Black women ( N = 348) under community supervision programs in New York City. Using secondary analysis, we used logistic models to test the association between factors related to mental health, substance use, and social determinants of health and follow-up assessment completion (three, six, and 12 months). Participants who were diagnosed with schizophrenia or food insecure in the past 90 days had lower odds of retention. Participants who misused prescription opiates during their lifetime had higher odds of retention throughout the intervention.
Keyphrases
- mental health
- healthcare
- antiretroviral therapy
- hiv positive
- randomized controlled trial
- hiv infected
- clinical trial
- mental illness
- polycystic ovary syndrome
- human immunodeficiency virus
- public health
- hiv testing
- hiv aids
- hepatitis c virus
- pregnancy outcomes
- bipolar disorder
- health information
- south africa
- breast cancer risk
- drug induced
- skeletal muscle
- climate change
- human health
- metabolic syndrome
- social media
- health promotion
- study protocol
- health insurance